Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1993 Feb;67(2):843–851. doi: 10.1128/jvi.67.2.843-851.1993

Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals.

I Bastian 1, J Gardner 1, D Webb 1, I Gardner 1
PMCID: PMC237438  PMID: 8093491

Abstract

A human T-lymphotropic virus type I (HTLV-I) strain was isolated in a CD4+ T-lymphocyte culture established from a healthy seropositive Australian Aboriginal. This isolate, identified as HTLV-IMSHR-1, was detected by immunofluorescence with monoclonal antibodies, by the presence of gag-encoded protein p24 in the culture supernatant, and by cocultivation leading to infection and transformation of lymphocytes from an HTLV-I-negative donor. By using the polymerase chain reaction technique, the env gene and segments of the pol and pX regions of the proviral genome of HTLV-I(MSHR-1) were amplified and sequenced. Comparison with the envelope sequences of prototype strains revealed up to 7% divergence at the nucleotide level and 3.1 to 4.3% divergence in the predicted amino acid sequence. Phylogenetic analysis showed that the Australian and Melanesian isolates are related. Differential reactivity with monoclonal antibodies suggests that gag protein p19 of HTLV-I(MSHR-1) is also divergent. The potential for antigenic divergence between the prototype HTLV-I isolates and the Austro-Melanesian variants requires further investigation, because it would have implications for serodiagnosis and vaccine development.

Full text

PDF
843

Images in this article

845Image
on p.845
845Image
on p.845
848Image
on p.848

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ajdukiewicz A., Yanagihara R., Garruto R. M., Gajdusek D. C., Alexander S. S. HTLV-1 myeloneuropathy in the Solomon Islands. N Engl J Med. 1989 Aug 31;321(9):615–616. doi: 10.1056/NEJM198908313210913. [DOI] [PubMed] [Google Scholar]
  2. Asher D. M., Goudsmit J., Pomeroy K. L., Garruto R. M., Bakker M., Ono S. G., Elliot N., Harris K., Askins H., Eldadah Z. Antibodies to HTLV-I in populations of the southwestern Pacific. J Med Virol. 1988 Dec;26(4):339–351. doi: 10.1002/jmv.1890260402. [DOI] [PubMed] [Google Scholar]
  3. Bangham C. R., Daenke S., Phillips R. E., Cruickshank J. K., Bell J. I. Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis. EMBO J. 1988 Dec 20;7(13):4179–4184. doi: 10.1002/j.1460-2075.1988.tb03314.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bartholomew C., Blattner W., Cleghorn F. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet. 1987 Dec 19;2(8573):1469–1469. doi: 10.1016/s0140-6736(87)91172-x. [DOI] [PubMed] [Google Scholar]
  5. Chen Y. M., Lee T. H., Samuel K. P., Okayama A., Tachibana N., Miyoshi I., Papas T. S., Essex M. Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people. J Virol. 1989 Nov;63(11):4952–4957. doi: 10.1128/jvi.63.11.4952-4957.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cianciolo G. J., Copeland T. D., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 1985 Oct 25;230(4724):453–455. doi: 10.1126/science.2996136. [DOI] [PubMed] [Google Scholar]
  7. Clapham P., Nagy K., Weiss R. A. Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera. Proc Natl Acad Sci U S A. 1984 May;81(9):2886–2889. doi: 10.1073/pnas.81.9.2886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Daenke S., Nightingale S., Cruickshank J. K., Bangham C. R. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol. 1990 Mar;64(3):1278–1282. doi: 10.1128/jvi.64.3.1278-1282.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ehrlich G. D., Poiesz B. J. Clinical and molecular parameters of HTLV-I infection. Clin Lab Med. 1988 Mar;8(1):65–84. [PubMed] [Google Scholar]
  10. Gallaher W. R., Ball J. M., Garry R. F., Griffin M. C., Montelaro R. C. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retroviruses. 1989 Aug;5(4):431–440. doi: 10.1089/aid.1989.5.431. [DOI] [PubMed] [Google Scholar]
  11. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  12. Gessian A., Yanagihara R., Franchini G., Garruto R. M., Jenkins C. L., Ajdukiewicz A. B., Gallo R. C., Gajdusek D. C. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7694–7698. doi: 10.1073/pnas.88.17.7694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gray G. S., White M., Bartman T., Mann D. Envelope gene sequence of HTLV-1 isolate MT-2 and its comparison with other HTLV-1 isolates. Virology. 1990 Jul;177(1):391–395. doi: 10.1016/0042-6822(90)90498-g. [DOI] [PubMed] [Google Scholar]
  14. Hanada S., Uematsu T., Iwahashi M., Nomura K., Utsunomiya A., Kodama M., Ishibashi K., Terada A., Saito T., Makino T. The prevalence of human T-cell leukemia virus type I infection in patients with hematologic and nonhematologic diseases in an adult T-cell leukemia-endemic area of Japan. Cancer. 1989 Sep 15;64(6):1290–1295. doi: 10.1002/1097-0142(19890915)64:6<1290::aid-cncr2820640620>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  15. Higgins D. G., Bleasby A. J., Fuchs R. CLUSTAL V: improved software for multiple sequence alignment. Comput Appl Biosci. 1992 Apr;8(2):189–191. doi: 10.1093/bioinformatics/8.2.189. [DOI] [PubMed] [Google Scholar]
  16. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K. I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476–6480. doi: 10.1073/pnas.78.10.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Horal P., Hall W. W., Svennerholm B., Lycke J., Jeansson S., Rymo L., Kaplan M. H., Vahlne A. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5754–5758. doi: 10.1073/pnas.88.13.5754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ina Y., Gojobori T. Molecular evolution of human T-cell leukemia virus. J Mol Evol. 1990 Dec;31(6):493–499. doi: 10.1007/BF02102076. [DOI] [PubMed] [Google Scholar]
  19. Kazura J. W., Saxinger W. C., Wenger J., Forsyth K., Lederman M. M., Gillespie J. A., Carpenter C. C., Alpers M. A. Epidemiology of human T cell leukemia virus type I infection in East Sepik Province, Papua New Guinea. J Infect Dis. 1987 Jun;155(6):1100–1107. doi: 10.1093/infdis/155.6.1100. [DOI] [PubMed] [Google Scholar]
  20. Kirkland M. A., Frasca J., Bastian I. Adult T-cell leukaemia lymphoma in an aborigine. Aust N Z J Med. 1991 Oct;21(5):739–741. doi: 10.1111/j.1445-5994.1991.tb01380.x. [DOI] [PubMed] [Google Scholar]
  21. Kwok S., Ehrlich G., Poiesz B., Kalish R., Sninsky J. J. Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood. 1988 Oct;72(4):1117–1123. [PubMed] [Google Scholar]
  22. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  23. Malik K. T., Even J., Karpas A. Molecular cloning and complete nucleotide sequence of an adult T cell leukaemia virus/human T cell leukaemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup. J Gen Virol. 1988 Jul;69(Pt 7):1695–1710. doi: 10.1099/0022-1317-69-7-1695. [DOI] [PubMed] [Google Scholar]
  24. Mamoun R. Z., Morisson M., Rebeyrotte N., Busetta B., Couez D., Kettmann R., Hospital M., Guillemain B. Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J Virol. 1990 Sep;64(9):4180–4188. doi: 10.1128/jvi.64.9.4180-4188.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. May J. T., Stent G., Schnagl R. D. Antibody to human T-cell lymphotropic virus type I in Australian aborigines. Med J Aust. 1988 Jul 18;149(2):104–104. doi: 10.5694/j.1326-5377.1988.tb120516.x. [DOI] [PubMed] [Google Scholar]
  26. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981 Dec 24;294(5843):770–771. doi: 10.1038/294770a0. [DOI] [PubMed] [Google Scholar]
  27. Nagy K., Clapham P., Cheingsong-Popov R., Weiss R. A. Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int J Cancer. 1983 Sep 15;32(3):321–328. doi: 10.1002/ijc.2910320310. [DOI] [PubMed] [Google Scholar]
  28. Page J. B., Lai S. H., Chitwood D. D., Klimas N. G., Smith P. C., Fletcher M. A. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet. 1990 Jun 16;335(8703):1439–1441. doi: 10.1016/0140-6736(90)91456-k. [DOI] [PubMed] [Google Scholar]
  29. Paine E., Garcia J., Philpott T. C., Shaw G., Ratner L. Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients. Virology. 1991 May;182(1):111–123. doi: 10.1016/0042-6822(91)90654-t. [DOI] [PubMed] [Google Scholar]
  30. Palker T. J., Riggs E. R., Spragion D. E., Muir A. J., Scearce R. M., Randall R. R., McAdams M. W., McKnight A., Clapham P. R., Weiss R. A. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J Virol. 1992 Oct;66(10):5879–5889. doi: 10.1128/jvi.66.10.5879-5889.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Palker T. J., Scearce R. M., Copeland T. D., Oroszlan S., Haynes B. F. C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope. J Immunol. 1986 Apr 1;136(7):2393–2397. [PubMed] [Google Scholar]
  32. Palker T. J., Scearce R. M., Miller S. E., Popovic M., Bolognesi D. P., Gallo R. C., Haynes B. F. Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV. J Exp Med. 1984 Apr 1;159(4):1117–1131. doi: 10.1084/jem.159.4.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Palker T. J., Tanner M. E., Scearce R. M., Streilein R. D., Clark M. E., Haynes B. F. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. J Immunol. 1989 Feb 1;142(3):971–978. [PubMed] [Google Scholar]
  34. Papsidero L., Swartzwelder F., Sheu M., Montagna R., Ehrlich G., Bhagavati S., Dosik H., Sninsky J., Poiesz B. Immunodetection of human T-cell lymphotropic virus type I core protein in biological samples by using a monoclonal antibody immunoassay. J Clin Microbiol. 1990 May;28(5):949–955. doi: 10.1128/jcm.28.5.949-955.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pique C., Tursz T., Dokhelar M. C. Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation? EMBO J. 1990 Dec;9(13):4243–4248. doi: 10.1002/j.1460-2075.1990.tb07872.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Popovic M., Sarin P. S., Robert-Gurroff M., Kalyanaraman V. S., Mann D., Minowada J., Gallo R. C. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science. 1983 Feb 18;219(4586):856–859. doi: 10.1126/science.6600519. [DOI] [PubMed] [Google Scholar]
  37. Reitz M. S., Jr, Wilson C., Naugle C., Gallo R. C., Robert-Guroff M. Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell. 1988 Jul 1;54(1):57–63. doi: 10.1016/0092-8674(88)90179-1. [DOI] [PubMed] [Google Scholar]
  38. Schulz T. F., Calabrò M. L., Hoad J. G., Carrington C. V., Matutes E., Catovsky D., Weiss R. A. HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. Virology. 1991 Oct;184(2):483–491. doi: 10.1016/0042-6822(91)90418-b. [DOI] [PubMed] [Google Scholar]
  39. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3618–3622. doi: 10.1073/pnas.80.12.3618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shimotohno K., Takahashi Y., Shimizu N., Gojobori T., Golde D. W., Chen I. S., Miwa M., Sugimura T. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci U S A. 1985 May;82(10):3101–3105. doi: 10.1073/pnas.82.10.3101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Taguchi H., Miyoshi I. Immune suppression in HTLV-I carriers: a predictive sign of adult T-cell leukemia. Acta Med Okayama. 1989 Dec;43(6):317–321. doi: 10.18926/AMO/30865. [DOI] [PubMed] [Google Scholar]
  42. Tanaka Y., Zeng L., Shiraki H., Shida H., Tozawa H. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol. 1991 Jul 1;147(1):354–360. [PubMed] [Google Scholar]
  43. Watanabe T., Seiki M., Tsujimoto H., Miyoshi I., Hayami M., Yoshida M. Sequence homology of the simian retrovirus genome with human T-cell leukemia virus type I. Virology. 1985 Jul 15;144(1):59–65. doi: 10.1016/0042-6822(85)90304-6. [DOI] [PubMed] [Google Scholar]
  44. Weber J. N., Banatvala N., Clayden S., McAdam K. P., Palmer S., Moulsdale H., Tosswill J., Dilger P., Thorpe R., Amann S. HTLV-1 infection in Papua New Guinea: evidence for serologic false positivity. J Infect Dis. 1989 Jun;159(6):1025–1028. doi: 10.1093/infdis/159.6.1025. [DOI] [PubMed] [Google Scholar]
  45. Yanagihara R., Ajdukiewicz A. B., Nerurkar V. R., Garruto R. M., Gajdusek D. C. Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification. Jpn J Cancer Res. 1991 Mar;82(3):240–244. doi: 10.1111/j.1349-7006.1991.tb01835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yanagihara R., Nerurkar V. R., Garruto R. M., Miller M. A., Leon-Monzon M. E., Jenkins C. L., Sanders R. C., Liberski P. P., Alpers M. P., Gajdusek D. C. Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1446–1450. doi: 10.1073/pnas.88.4.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES